Literature DB >> 22977419

Triple Therapy for Moderate-to-Severe Chronic Obstructive Pulmonary Disease.

.   

Abstract

Entities:  

Year:  2010        PMID： 22977419      PMCID： PMC3411162     

Source DB:  PubMed          Journal:  CADTH Technol Overv        ISSN： 1203-9012


× No keyword cloud information.
  10 in total

Review 1.  Outcomes for COPD pharmacological trials: from lung function to biomarkers.

Authors:  M Cazzola; W MacNee; F J Martinez; K F Rabe; L G Franciosi; P J Barnes; V Brusasco; P S Burge; P M A Calverley; B R Celli; P W Jones; D A Mahler; B Make; M Miravitlles; C P Page; P Palange; D Parr; M Pistolesi; S I Rennard; M P Rutten-van Mölken; R Stockley; S D Sullivan; J A Wedzicha; E F Wouters
Journal:  Eur Respir J       Date:  2008-02       Impact factor: 16.671

2.  A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.

Authors:  Mario Cazzola; Filippo Andò; Pierachille Santus; Paolo Ruggeri; Fabiano Di Marco; Alessandro Sanduzzi; Maria D'Amato
Journal:  Pulm Pharmacol Ther       Date:  2006-07-07       Impact factor: 3.410

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.

Authors:  R A Pauwels; A S Buist; P Ma; C R Jenkins; S S Hurd
Journal:  Respir Care       Date:  2001-08       Impact factor: 2.258

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 5.  Airway inflammation in chronic obstructive pulmonary disease.

Authors:  M Saetta
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

6.  Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Dean Fergusson; François Maltais; Jean Bourbeau; Roger Goldstein; Meyer Balter; Denis O'Donnell; Andrew McIvor; Sat Sharma; Graham Bishop; John Anthony; Robert Cowie; Stephen Field; Andrew Hirsch; Paul Hernandez; Robert Rivington; Jeremy Road; Victor Hoffstein; Richard Hodder; Darcy Marciniuk; David McCormack; George Fox; Gerard Cox; Henry B Prins; Gordon Ford; Dominique Bleskie; Steve Doucette; Irvin Mayers; Kenneth Chapman; Noe Zamel; Mark FitzGerald
Journal:  Ann Intern Med       Date:  2007-02-19       Impact factor: 25.391

7.  [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].

Authors:  Li-Zhou Fang; Xiao Liang; Jian-Qing Zhang; Ling Liu; Wei-Ping Fu; Zhi-Huan Zhao; Lu-Ming Dai
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2008-11

8.  State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease.

Authors:  Denis E O'Donnell; Shawn Aaron; Jean Bourbeau; Paul Hernandez; Darcy Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Roger Goldstein; Rick Hodder; Francois Maltais; Jeremy Road; Valoree McKay; Jennifer Schenkel; Annon Ariel; Anna Day; Yves Lacasse; Robert Levy; Dale Lien; John Miller; Graeme Rocker; Tasmin Sinuff; Paula Stewart; Nha Voduc; Raja Abboud; Amnon Ariel; Margo Becklake; Elizabeth Borycki; Dina Brooks; Shirley Bryan; Luanne Calcutt; Ken Chapman; Nozhat Choudry; Alan Couet; Steven Coyle; Arthur Craig; Ian Crawford; Mervyn Dean; Ronald Grossman; Jan Haffner; Daren Heyland; Donna Hogg; Martin Holroyde; Alan Kaplan; John Kayser; Dale Lein; Josiah Lowry; Les McDonald; Alan MacFarlane; Andrew McIvor; John Rea; Darlene Reid; Michel Rouleau; Lorelei Samis; Don Sin; Katherine Vandemheen; J A Wedzicha; Karl Weiss
Journal:  Can Respir J       Date:  2004 Jul-Aug       Impact factor: 2.409

Review 9.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

Authors:  Denis E O'Donnell; Shaw Aaron; Jean Bourbeau; Paul Hernandez; Darcy D Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Rogers Goldstein; Rick Hodder; Alan Kaplan; Sean Keenan; Yves Lacasse; Francois Maltais; Jeremy Road; Graeme Rocker; Don Sin; Tasmin Sinuff; Nha Voduc
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409

10.  Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.

Authors:  Tobias Welte; Marc Miravitlles; Paul Hernandez; Göran Eriksson; Stefan Peterson; Tomasz Polanowski; Romain Kessler
Journal:  Am J Respir Crit Care Med       Date:  2009-07-30       Impact factor: 21.405
  10 in total
  2 in total

1.  Initiation of triple therapy maintenance treatment among patients with COPD in the US.

Authors:  Jason C Simeone; Rakesh Luthra; Shuchita Kaila; Xiaoyun Pan; Tarun D Bhagnani; Jieruo Liu; Teresa K Wilcox
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-22

2.  The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.

Authors:  Guy Brusselle; David Price; Kevin Gruffydd-Jones; Marc Miravitlles; Dorothy L Keininger; Rebecca Stewart; Michael Baldwin; Rupert C Jones
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.